These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9712172)

  • 1. Evidence for the involvement of nitric oxide in the inhibitory effect of GSPYFVamide on Helix aspersa central neurones.
    Pedder SM; Muneoka Y; Walker RJ
    Regul Pept; 1998 Jun; 74(2-3):121-7. PubMed ID: 9712172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide-cyclic GMP pathway and synaptic plasticity in the rat superior cervical ganglion.
    Southam E; Charles SL; Garthwaite J
    Br J Pharmacol; 1996 Oct; 119(3):527-32. PubMed ID: 8894173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial studies on the direct and modulatory effects of nitric oxide on an identified central Helix aspersa neuron.
    Wright NJ; Sides LJ; Walling K
    Invert Neurosci; 2015; 15(1):175. PubMed ID: 25380983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide inhibits whole-cell current in cystic fibrosis pancreatic epithelial cells.
    Thethi K; Duszyk M
    Pancreas; 1999 Aug; 19(2):158-66. PubMed ID: 10438163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F; Schmidt K; Nielsen EB; Mayer B
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a novel guanylate cyclase inhibitor on nitric oxide-dependent inhibitory neurotransmission in canine proximal colon.
    Franck H; Sweeney KM; Sanders KM; Shuttleworth CW
    Br J Pharmacol; 1997 Nov; 122(6):1223-9. PubMed ID: 9401790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide modulates the release of serotonin in the rat hypothalamus.
    Kaehler ST; Singewald N; Sinner C; Philippu A
    Brain Res; 1999 Jul; 835(2):346-9. PubMed ID: 10415393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL; Wu CC; Teng CM
    Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
    Mulè F; D'Angelo S; Serio R
    Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide: a trigger for classic preconditioning?
    Lochner A; Marais E; Genade S; Moolman JA
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2752-65. PubMed ID: 11087230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.
    Nisoli E; Clementi E; Tonello C; Sciorati C; Briscini L; Carruba MO
    Br J Pharmacol; 1998 Oct; 125(4):888-94. PubMed ID: 9831929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15.
    Loweth AC; Williams GT; Scarpello JH; Morgan NG
    FEBS Lett; 1997 Jan; 400(3):285-8. PubMed ID: 9009215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric-oxide-dependent activation of pig oocytes: the role of the cGMP-signalling pathway.
    Petr J; Rajmon R; Chmelíková E; Tománek M; Lánská V; Pribánová M; Jílek F
    Zygote; 2006 Feb; 14(1):9-16. PubMed ID: 16700970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate relaxes the isolated bovine ophthalmic artery: involvement of phosphoinositide 3-kinase-Akt-nitric oxide/cGMP signalling pathway.
    Romano MR; Lograno MD
    Eur J Pharmacol; 2009 Apr; 608(1-3):48-53. PubMed ID: 19249297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
    Filippov G; Bloch DB; Bloch KD
    J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
    Callsen D; Pfeilschifter J; Brüne B
    J Immunol; 1998 Nov; 161(9):4852-8. PubMed ID: 9794418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.